Press release
Global Respiratory Disease Vaccine Market is Forecast to Reach a Value of USD 28 Billion By 2030 with a Growing CAGR of 5% | Infinium Global Research
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/560
Market Insight:
The global respiratory disease vaccine market, valued at over USD 18 billion in 2022, is projected to surpass USD 28 billion by 2030, exhibiting a steady CAGR of above 5% throughout the forecast period from 2023 to 2030.
Respiratory diseases encompass ailments affecting the lungs and respiratory system, stemming from various factors like smoking, infections, pollution, and asbestos exposure. Preventing these diseases through vaccination is pivotal, reducing infection burdens, hospitalizations, and antibiotic prescriptions for complications. Pneumococcal vaccines, PCV13, and PPSV23 are commonly recommended for adults aged 65 or older, particularly those with chronic lung conditions like COPD.
Market Drivers and Opportunities:
The prevalence of respiratory diseases like asthma, tuberculosis, pneumonia, and lung cancer drives market growth. Asthma and Chronic Obstructive Pulmonary Disease (COPD) are significant chronic respiratory diseases affecting lung airways. While healthcare expenditure supports growth, stringent government policies for vaccine approvals may pose challenges. However, increased funding for respiratory disease vaccine research presents opportunities for market expansion.
Geographic Dynamics:
North America leads the respiratory disease vaccine market due to a rising prevalence of respiratory illnesses, including COPD, asthma, and pulmonary hypertension. Government initiatives supporting R&D in vaccination, high healthcare expenditure, and robust healthcare infrastructure contribute to market dominance. In Asia-Pacific, growing R&D activities and healthcare investments are expected to drive market growth.
Segments Covered:
The report segments the global respiratory disease vaccine market based on disease type (COPD, pertussis, pneumonia, measles, diphtheria) and vaccines (DTaP, PPSV23, MMR, Hib, RSV).
Companies Profiled:
Infinium Global Research profiles key market players like Sanofi, GSK plc, Merck & Co., Inc., Pfizer Inc., Bavarian Nordic, EMERGENT, CSL Limited, Moderna, Inc., Serum Institute of India Pvt. Ltd., and Sinovac Biotech. among others, offering insights into their roles in shaping the evolving respiratory disease vaccine market.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/560
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Respiratory Disease Vaccine Market Highlights
2.2. Respiratory Disease Vaccine Market Projection
2.3. Respiratory Disease Vaccine Market Regional Highlights
Chapter 3. Global Respiratory Disease Vaccine Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter`s Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Disease Type
3.4.2. IGR-Growth Matrix Analysis by Vaccine
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Respiratory Disease Vaccine Market
Chapter 4. Respiratory Disease Vaccine Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Respiratory Disease Vaccine Market
5.2. Companies Profiles
5.2.1. Sanofi
5.2.2. GSK plc
5.2.3. Merck & Co., Inc.
5.2.4. Pfizer Inc.
5.2.5. Bavarian Nordic
5.2.6. EMERGENT
5.2.7. CSL Limited
5.2.8. Moderna, Inc.
5.2.9. Serum Institute of India Pvt. Ltd.
5.2.10. Sinovac Biotech
Chapter 6. Global Respiratory Disease Vaccine Market by Disease Type
6.1. Chronic Obstructive Pulmonary Disease (COPD)
6.2. Pertussis
6.3. Pneumonia
6.4. Measles
6.5. Diphtheria
Chapter 7. Global Respiratory Disease Vaccine Market by Vaccine
7.1. DTaP
7.2. PPSV23
7.3. MMR
7.4. Haemophilus Influenzae Type B (HIB)
7.5. Respiratory Syncytial Virus (RSV)
Chapter 8. Global Respiratory Disease Vaccine Market by Region 2023-2030
8.1. North America
8.1.1. North America Respiratory Disease Vaccine Market by Disease Type
8.1.2. North America Respiratory Disease Vaccine Market by Vaccine
8.1.3. North America Respiratory Disease Vaccine Market by Country
8.1.3.1. The U.S. Respiratory Disease Vaccine Market
8.1.3.1.1. The U.S. Respiratory Disease Vaccine Market by Disease Type
8.1.3.1.2. The U.S. Respiratory Disease Vaccine Market by Vaccine
8.1.3.2. Canada Respiratory Disease Vaccine Market
8.1.3.2.1. Canada Respiratory Disease Vaccine Market by Disease Type
8.1.3.2.2. Canada Respiratory Disease Vaccine Market by Vaccine
8.1.3.3. Mexico Respiratory Disease Vaccine Market
8.1.3.3.1. Mexico Respiratory Disease Vaccine Market by Disease Type
8.1.3.3.2. Mexico Respiratory Disease Vaccine Market by Vaccine
8.2. Europe
8.2.1. Europe Respiratory Disease Vaccine Market by Disease Type
8.2.2. Europe Respiratory Disease Vaccine Market by Vaccine
8.2.3. Europe Respiratory Disease Vaccine Market by Country
8.2.3.1. Germany Respiratory Disease Vaccine Market
8.2.3.1.1. Germany Respiratory Disease Vaccine Market by Disease Type
8.2.3.1.2. Germany Respiratory Disease Vaccine Market by Vaccine
8.2.3.2. United Kingdom Respiratory Disease Vaccine Market
8.2.3.2.1. United Kingdom Respiratory Disease Vaccine Market by Disease Type
8.2.3.2.2. United Kingdom Respiratory Disease Vaccine Market by Vaccine
8.2.3.3. France Respiratory Disease Vaccine Market
8.2.3.3.1. France Respiratory Disease Vaccine Market by Disease Type
8.2.3.3.2. France Respiratory Disease Vaccine Market by Vaccine
8.2.3.4. Italy Respiratory Disease Vaccine Market
8.2.3.4.1. Italy Respiratory Disease Vaccine Market by Disease Type
8.2.3.4.2. Italy Respiratory Disease Vaccine Market by Vaccine
8.2.3.5. Rest of Europe Respiratory Disease Vaccine Market
8.2.3.5.1. Rest of Europe Respiratory Disease Vaccine Market by Disease Type
8.2.3.5.2. Rest of Europe Respiratory Disease Vaccine Market by Vaccine
8.3. Asia Pacific
8.3.1. Asia Pacific Respiratory Disease Vaccine Market by Disease Type
8.3.2. Asia Pacific Respiratory Disease Vaccine Market by Vaccine
8.3.3. Asia Pacific Respiratory Disease Vaccine Market by Country
8.3.3.1. China Respiratory Disease Vaccine Market
8.3.3.1.1. China Respiratory Disease Vaccine Market by Disease Type
8.3.3.1.2. China Respiratory Disease Vaccine Market by Vaccine
8.3.3.2. Japan Respiratory Disease Vaccine Market
8.3.3.2.1. Japan Respiratory Disease Vaccine Market by Disease Type
8.3.3.2.2. Japan Respiratory Disease Vaccine Market by Vaccine
8.3.3.3. India Respiratory Disease Vaccine Market
8.3.3.3.1. India Respiratory Disease Vaccine Market by Disease Type
8.3.3.3.2. India Respiratory Disease Vaccine Market by Vaccine
8.3.3.4. South Korea Respiratory Disease Vaccine Market
8.3.3.4.1. South Korea Respiratory Disease Vaccine Market by Disease Type
8.3.3.4.2. South Korea Respiratory Disease Vaccine Market by Vaccine
8.3.3.5. Australia Respiratory Disease Vaccine Market
8.3.3.5.1. Australia Respiratory Disease Vaccine Market by Disease Type
8.3.3.5.2. Australia Respiratory Disease Vaccine Market by Vaccine
8.3.3.6. Rest of Asia-Pacific Respiratory Disease Vaccine Market
8.3.3.6.1. Rest of Asia-Pacific Respiratory Disease Vaccine Market by Disease Type
8.3.3.6.2. Rest of Asia-Pacific Respiratory Disease Vaccine Market by Vaccine
8.4. RoW
8.4.1. RoW Respiratory Disease Vaccine Market by Disease Type
8.4.2. RoW Respiratory Disease Vaccine Market by Vaccine
8.4.3. RoW Respiratory Disease Vaccine Market by Sub-region
8.4.3.1. Latin America Respiratory Disease Vaccine Market
8.4.3.1.1. Latin America Respiratory Disease Vaccine Market by Disease Type
8.4.3.1.2. Latin America Respiratory Disease Vaccine Market by Vaccine
8.4.3.2. Middle East Respiratory Disease Vaccine Market
8.4.3.2.1. Middle East Respiratory Disease Vaccine Market by Disease Type
8.4.3.2.2. Middle East Respiratory Disease Vaccine Market by Vaccine
8.4.3.3. Africa Respiratory Disease Vaccine Market
8.4.3.3.1. Africa Respiratory Disease Vaccine Market by Disease Type
8.4.3.3.2. Africa Respiratory Disease Vaccine Market by Vaccine
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/560
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of respiratory disease vaccine.
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027
About Infinium Global Research:
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Respiratory Disease Vaccine Market is Forecast to Reach a Value of USD 28 Billion By 2030 with a Growing CAGR of 5% | Infinium Global Research here
News-ID: 3310738 • Views: …
More Releases from Infinium Global Research LLP
Saudi Arabia Healthcare Cybersecurity Market is Expected to Reach USD 1650 Milli …
The Saudi Arabia healthcare cybersecurity market has entered a phase of accelerated growth, driven by the country's ongoing digital transformation and the rapid adoption of advanced healthcare IT platforms. Valued at USD 540 million in 2023, the market is projected to reach USD 1,650 million by 2032, expanding at a CAGR of 15% during 2024-2032. This growth is fueled by the Kingdom's National e-Health Strategy, rising cyberthreats targeting healthcare systems,…
Global Aviation Fuel Market Outlook 2024-2032: Growth from USD 289.34 Billion to …
The aviation fuel market has expanded steadily in recent years, driven by rising global air traffic, economic improvements, and the rapid expansion of commercial and cargo aviation networks. The market was valued at USD 289.34 billion in 2023 and is projected to reach USD 437.34 billion by 2032, reflecting stable expansion supported by increasing aircraft operations, modernization of fleets, and the growing need for reliable fuel logistics. Key growth drivers…
United States Beauty and Wellness Market is Expected to Reach USD 143.27 Million …
The United States beauty and wellness market continues to evolve rapidly, shaped by shifting consumer priorities, rising disposable incomes, digital-first retail strategies, and the strong influence of self-care culture. With a valuation of USD 97 billion in 2023, the market is firmly positioned as one of the world's largest and most dynamic consumer-driven sectors. Increased awareness of holistic wellbeing, demand for clean beauty solutions, and adoption of premium skincare and…
United States Pharmerging Market is Expected to Reach USD 1172.82 Billion in 203 …
The United States pharmerging market has emerged as one of the fastest-growing components of the broader healthcare and pharmaceutical ecosystem, driven by rapid advancements in drug manufacturing, rising healthcare expenditure, and a surge in lifestyle-related diseases. Valued at USD 540 billion in 2023, the market is projected to reach USD 1172.82 billion by 2032, expanding at a CAGR of 9% during 2024-2032. This growth reflects the country's robust pharmaceutical infrastructure…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
